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INTRODUCTION            
Polymers are macro molecules made up of repeating units 
called “monomers” joined by the same type of linkage. 
Starch cellulose & rubber all possesses polymeric 
properties. Man made polymers have been studied since 
1832. We are surrounded by polymers every day, every 
where.1 We wear clothes containing polyester & nylon 
fibers, food packaged in polyethylene container, pipe, walk 
on carpets made of polyolefin & sleep on  mattresses made 
of poly urethane foam. Polyglycolic acid (PGA) was such 
a polymer, used in surgical sutures by surgeons.Many 
biomaterials, especially heart valve replacement & blood 
vessels are made of polymers like Dacron, Teflon & 
polyurethane. In 1950, synthetic organic polymers were 
first used as ion exchange resins for the separation of 
pharmaceutical products . 
Polumeres (having many parts), Johan JaKob Berzelius 
introduced this term in 1830.since most of the functional 
groups present are carboxylic acid esters, thus quite 
logically, these macromolecules belong to the class of 
polymers known as polyesters.2 A typical polymer consists 
of more than 10,000 atoms. Macromolecules are so 
common in everyday life that people hardly notice their 
presence. Chemists have learned how to manufacture 
macromolecules in the lab, but nature masters the 
techniques eons ago. All living cells produce a complex 
array of different types of macromolecules. Plants and 
animals contain a rich variety of biochemical 
macromolecules.3 Polymers (Greek-POLY…many and 
MEROS…parts) are macromolecules made up of repeating 
units called „monomers‟ joined by the same type of 
linkage. The suffix in polymer „mer‟ is originated from 
Greek word meros which means part. The word polymer is 
thus coined to mean material consisting of many 
parts/mers. Most of the polymers are basically organic 
compounds, however they can be inorganic (e.g. silicones 
based on Si-O network).4 Synthetic polymers are of 
increasing interest in drug delivery as therapeutic agent. 
Polymers show usually an improved pharmacokinetics 
compared to small molecule drugs with longer circulation 
time and the potential for tissue targeting. Synthetic 
polymers are being used as drug delivery systems as a 
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polymeric drug itself or in combination with small 
molecule drugs or with bio macromolecules such as 
proteins and poly (nucleic acids).5  
In 1970, yolles & coworker demonstrated lactic acid based 
polymer used for controlled drug delivery of steroids, 
opening grounds for the exciting fields of polymeric drug 
delivery. Controlled drug delivery occurs, when a polymer 
is judiciously combined with a drug or other active agent 
in such a way that the active agent is released from the 
material in a predesigned manner. 6 In controlled drug 
delivery systems designed for long term administration the 
drug level remaining constant, between the desired 
maximum & minimum, for an extended period of time. 
Pharmaceutical applications of polymers range from their 
use as binders in tablets to viscosity & flow controlling 
agents in liquids, suspensions & emulsions polymers can 
be used as film coatings to disguise the unpleasant taste of 
a drug, to enhance drug stability & to modify drug release 
characters. Advantages of controlled release devices 
possibly include delivery to the required site, delivery at 
the required rate, reduced dangers of overdose or Side 
effects. 7,8 
Microcapsules are a small sphere with a uniform wall 
around it. Most microcapsule has diameters b/w a few 
micro meters & a few millimeters.9 Micro-encapsulations 
can be used to slow release of a drug into the body. This 
may permit one controlled release dose to substitute for 
several doses of non-encapsulated drug & also may 
decrease toxic side effects for some drug & by preventing 
high initial concentration in the blood, morphology of 
polymer matrix play an important role in governing the 
release characteristic of the encapsulated drug.10 Polymer 
matrix could be formulated as micro/nanospheres, gel film 
or an extruded shape. The shape of extruded polymer can 
be important to the drug release kinetics. Zero order 
kinetics be achieved using a hemispherical polymer form. 
Polymeric drug delivery products can be formulated with 
excipients added to the polymer matrix.11 The main 
objective of having excipients in the polymer either to 
modulate the drug release or to stabilize the drug or to 
modulate the polymer degradation kinetics12. 
Enteric coatings consist of pH sensitive polymers which 
are unionized at low pH (in stomach); at high pH (in 
intestine) the polymers ionize causing swelling, or 
dissolving of the polymer. Formulation that can not the 
rate & period of drug delivery & target specific areas of 
the body treatment become increasingly & complex.13  
Challenges to not only development of new treatments but 
also the mechanism with which to administer them.14 
Therapeutic uses of a drug carrier system have significant 
impact on the treatment & potential cure of many chronic 
diseases, including cancer, diabetes mellitus, Rheumatoid 
arthritis, HIV infection & drug addiction.   
MATERIAL AND METHODS: 
Materials 
Various chemical and reagents used during synthesis of 
polymers like Acrylic Acid (Thomas Baker), Azobis-iso 
butyronitrile (Merck), Chloroform( Merck), Hydroquinone 
(Qualigens), Ethylmethacrylate(Merck), 
Methanol(Rankem), Petroleum Ether(Rankem), anhydrous 
Sodium Sulphate (Qualigens), Potassium chloride 
(Rankem), Hydrochloric acid(Qualigens), Potassium 
hydrogen Phthalate(Merck), Sodium Hydroxide(Rankem), 
Potassium dihydrogen phosphate(Qualigens), Boric 
acid(Rankem), Dichloromethane(Merck), Potassium 
chloride(Merck) and Acetone(Merck). 
 Purification and polymerization of monomers 
Monomers which are previously synthesized i.e.; 
Ethylmethacrylate and acrylic acid were distilled under 
vacuum with 1 gm of hydroquinone (as polymerization 
inhibitor) was added to it. This mixture was heated for 1hr 
at 40oC then distilled off under reduced pressure of 15 
mbar. This reaction mixture was distilled at 99oC & 
purified monomers were collected on an ice bath & stored 
in refrigerator. 
Polymers were prepared by using solution polymerization 
technique and mechanism involved is free radical 
mechanism. The polymers were prepared in a test tube, 5 
ml THF (as a solvent) and AIBN (as initiator) and specific 
molar quantities of monomers as mentioned in table (1) 
was taken. This mixture was agitated properly for 5 min, 
and then N2 gas was slowly purged to this reaction mixture 
for 5 min and was kept in thermostat water bath at 650 C 
over night (15-16 hrs). After 15-16 hrs the polymer was 
synthesized, this was in solution form. The precipitated 
polymers were dried at room temperature and stored. EMA 
& AA were used in combination for polymerization.  
Swelling studies of synthesized polymers in different 
pH. 
For swelling studies, in different pH buffer solutions i.e; 
Hydrochloric acid buffer pH 1.2,  Hydrochloric acid buffer 
pH 2.0, Phosphate buffer pH 6.0, Phosphate buffer pH 7.4, 
Phosphate buffer pH 7.8, Phosphate buffer pH 8.0.These 
different pH buffer solutions were prepared according to 
Indian Pharmacopoeia 2007.  Films of above polymers 
were prepared. For swelling studies, 15 ml of each of the 
above buffer was taken in four different test tubes for each 
polymer. Approximately 5-6 mm2 in size and 10-15 mg in 
weight polymeric films were placed in each test tube. The 
changes in films in phosphate buffer (pH 7.4, and pH 8.0), 
after 15, 30, 45, 60, 90,120 minutes were noted (table 1, 
2). In buffer (pH 6.0, pH2.0,and pH 1.2) the changes were 
noted after 1 hour,2 hour, 2days,3 days,4 days,5 days,6 
days,7 days(table 3,4,5 ).Swelling ratio(Q)  was  calculated 
by the formula:  Ww-WD/WD × 100. Where WD=Dry 
(initial) weight of polymeric film (mg), Ww (final) weight 
of polymeric film (mg). 
Microencapsulation of model drug 
Paracetamol (Ranbaxy pharmaceutical Ltd) drug was taken 
as model drug for microencapsulation. 100 mg of 
microspheres crushed & totally dissolved in a 100 ml 
solution containing 1 volume phosphate buffer (pH 7.4) & 
1volume methanol & further diluted with buffer. The drug 
was estimated by UV spectrophotometer at 249 nm using a 
calibration curve based on standard solutions. The 
percentage of Paracetamol encapsulated with respect to 
total amount of Paracetamol encapsulation taken loading 
efficacy.      
In vitro dissolution release of Paracetamol from micro 
spheres was evaluated using paddle dissolution apparatus. 
Dissolution media was 900 ml phosphate buffer (pH 7.4) 
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& to this media the microspheres containing 200 mg of 
Paracetamol were added. The system was stirred at 500 pm 
& temp at 37oC± 0.5 oC  samples were drawn at specified 
time intervals (10 min, 20 min, 30 min, 40 min, 50 min & 
60 min) filtered & assayed spectrophotometrically  at 
249nm. 
RESULT AND DISCUSSION 
We took synthesized  monomer in combination i.e. 
ethylmethacrylate (EMA) & Acrylic acid(AA) in different 
ratio molar quantities the percentage yield as follow- 
EMA(0.7): AA(0.3) Polymer yield 4.91 gm (98.45 %), 
EMA(0.6) : AA(0.4) 3.47 gm(96.96%), EMA(0.5) : 
AA(0.5) polymer yield 5.90gm (94.81%), EMA (0.4): AA 
(0.6): polymer yield 4.33 gm (99.12%), EMA (0.3): MA 
(0.7) yield 4.43 gm (99.03%). 
Synthesized copolymers were screened for swelling & 
dissolution behavior in pH1.2, pH 2.0, pH 6.0, pH 7.4 & 
pH 8.0 (table 1,2,3,4, and table 5). It was expected that 
copolymer should be solubilized with in the desired time in 
alkaline pH buffers (7.4 & 8.0), but do not in acidic buffers 
(pH 1.2 - pH 6.0) due to presence of acidic groups.  
From the swelling study it was observed that the 
copolymer of ethylmethacrylate : acrylic acid with 
monomeric ratio 7:3, 6:4 & 5:5 did not dissolved into the 
basic buffer due to low acidic monomer content. Whereas 
copolymer ethylmethacrylate : acrylic acid with 
monomeric ratio 4:6 shows good swelling characteristic 
but do not dissolved completely within the desired time. 
The copolymer ethylmethacrylate: acrylic acid with 
monomer 3:7 completely dissolved with in 2 hrs.  The 
copolymer with monomeric ratio 3:7 dissolved maximum 
within the desired time. The drug (Paracetamol) content in 
the microspheres of copolymer MMA (0.3): AA (0.7) 
Paracetamol percentage loading 41% & loading efficiency 
33.33%. Microspheres showed in basic media release 
about 60% within 30 min & 95%with in 1 hour. Which is 
explained the curve plotted between percentage release v/s 
time (figure A). All the copolymers did not show good 
swelling or dissolution characteristic in acidic pH (1.2, 2.0, 
and 6.0). 
  
Table 1: Swelling Studies in Phosphate Buffer pH 1.2 
 
The values given in brackets are molar quantity of monomers. 
Table 2: Swelling Studies in Phosphate Buffer pH 2.0 
 
The values given in brackets are molar quantity of monomers. 
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Table 3: Swelling Studies in Phosphate Buffer pH 6.0 
 
The values given in brackets are molar quantity of monomers. 
Table 4: Swelling Studies in Phosphate Buffer pH 7.4  
 
The values given in brackets are molar quantity of monomers. 
Table 5: Swelling Studies in Phosphate Buffer pH  8.0   
 
The values given in brackets are molar quantity of monomers. 
Drug Content of Microspheres 
                      The drug content in microspheres of co polymer MMA (0.3): AA (0.7)  follows as:- 
                       Paracetamol (%) loading = 41.0% 
                      Loading Efficiency (%)  = 33.33% 
In Vitro release study for microspheres  
The microspheres prepared were showed as release in basic media of about 60% with in the 30 min and 95% with in the 1 
hour as shown   in the curve plotted between percentage releases v/s time. 
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Figure 1: In vitro release of Drug from Microspheres 
CONCLUSION:  
In the present work, pH sensitive, biodegradable copolymers 
have been developed by free radical polymerization using 
Azobis-iso butyronitrile (AIBN) as an Initiator. The 
copolymer with monomeric ratio 3:7 dissolved maximum 
within the desired time. It was observed that swelling was 
also increased at higher pH due to availability of more ionized 
carboxylic group of acrylic acid. The result confirms that the 
copolymers ethylmethacrylate(EMA): acrylic acid(AA) with 
the ratio 3:7 can play an important role in oral pharmaceutical  
formulations as film coating agents or in controlled release  
drug delivery system. 
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